Brief: ESAB Q2 Core Adjusted EBITDA USD 127 Million
01/08/2023 11:30
Aug 01 (Reuters) - ESAB Outlook FY Core Sales Growth 6-7.5%. * Outlook FY Core Organic Growth 4-5.5%
Recent news on ESAB
See all newsBrief: ESAB Corp - Declares QTRLY Cash Dividend Of $0.12 Per Share
Esab Corp Reports Results For The Quarter Ended June 30: Earnings Summary
ESAB Corp beats Q2 sales estimates, raises FY core net sales growth
U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation
Brief: Esab - Appoints Mitchell P. Rales As Executive Chair Effective June 10, 2026 - SEC Filing